Paeoniflorin suppresses pancreatic cancer cell growth by upregulating HTRA3 expression
Drug Design, Development and Therapy Aug 31, 2017
Li YJ, et al. – The researchers explored the effects of paeoniflorin (PF) in pancreatic cancer. They provided genetic proofs and biological proofs that PF inhibited pancreatic cancer growth by upregulating HTRA3.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
